News archive
GLP‑1 news from 2011
1 dated, sourced GLP-1 developments from 2011: approvals, trial results, prices, lawsuits, compounding and culture.
- Business
Zyprexa patent loss in 2011 opened Eli Lilly's four-drug patent cliff
Eli Lilly's antipsychotic Zyprexa lost U.S. patent protection in October 2011, the first of four blockbuster medicines to lose exclusivity between 2011 and 2014. Company sales fell from a peak of $23.3 billion in 2011 to $19.6 billion in 2014, and Lilly kept its dividend and research spending rather than merge.